Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989

The Molecular Signatures Database Hallmark Gene Set Collection

Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239

Comprehensive molecular portraits of human breast tumours

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129

Finding community structure in very large networks

Clauset, A., Newman, M. E. J., & Moore, C. (2004) · Physical Review E · doi:10.1103/physreve.70.066111 · Cited by 7,390

Sparse inverse covariance estimation with the graphical lasso

Friedman, J., Hastie, T., & Tibshirani, R. (2008) · Biostatistics · doi:10.1093/biostatistics/kxm045 · Cited by 6,355

voom: precision weights unlock linear model analysis tools for RNA-seq read counts

Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155

limma: Linear Models for Microarray Data

Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796

Fitting a mixture model by expectation maximization to discover motifs in biopolymers.

Bailey, T. L., & Elkan, C. (1994) · PubMed · Cited by 4,982

Comprehensive genomic characterization of head and neck squamous cell carcinomas

The Cancer Genome Atlas Network (2015) · Nature · doi:10.1038/nature14129 · Cited by 4,147

Antisense oligonucleotide-mediated TRA2β poison exon inclusion induces the expression of a lncRNA with anti-tumor effects

Leclair, N. K., Brugiolo, M., Park, S., Devoucoux, M., Urbanski, L. M., Angarola, B. L., Yurieva, M., & Anczuków, O. (2025) · Nature Communications · doi:10.1038/s41467-025-56913-8 · Cited by 23

The splicing regulatory factor hnRNPU is a novel transcriptional target of c‐Myc in hepatocellular carcinoma

Zhang, B., Wang, H., Zhao, D., Wang, D., Zeng, Q., Xi, J., Nan, X., He, L., Zhou, J., Pei, X., et al. (2020) · FEBS Letters · doi:10.1002/1873-3468.13943 · Cited by 23

Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation

Mucha, B., Qie, S., Bajpai, S., Tarallo, V., Diehl, J. N., Tedeschi, F., Zhou, G., Gao, Z., Flashner, S., Klein-Szanto, A. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34402-6 · Cited by 23

Deconvolution of seed and RNA-binding protein crosstalk in RNAi-based functional genomics

Suzuki, H. I., Spengler, R. M., Grigelioniene, G., Kobayashi, T., & Sharp, P. A. (2018) · Nature Genetics · doi:10.1038/s41588-018-0104-1 · Cited by 23

Gene Regulatory Network Perturbation by Genetic and Epigenetic Variation

Li, Y., McGrail, D. J., Xu, J., Mills, G. B., Sahni, N., & Yi, S. S. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.05.002 · Cited by 21

Alternative splicing level related to intron size and organism complexity

Yang, P., Wang, D., & Kang, L. (2021) · BMC Genomics · doi:10.1186/s12864-021-08172-2 · Cited by 22

APOBEC Alteration Contributes to Tumor Growth and Immune Escape in Pan-Cancer

Guo, H., Zhu, L., Huang, L., Sun, Z., Zhang, H., Nong, B., & Xiong, Y. (2022) · Cancers · doi:10.3390/cancers14122827 · Cited by 25

Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer

Pu, S., Zhou, Y., Xie, P., Gao, X., Liu, Y., Ren, Y., He, J., & Hao, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.964118 · Cited by 21

RNA-binding protein RBM28 can translocate from the nucleolus to the nucleoplasm to inhibit the transcriptional activity of p53

Lin, X., Zhou, L., Zhong, J., Zhong, L., Zhang, R., Kang, T., & Wu, Y. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101524 · Cited by 20

Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance

Pan, S., Song, C., Meng, H., Li, N., Li, D., Hao, B., Lu, Z., & Geng, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.934722 · Cited by 20

RBM24 in the Post-Transcriptional Regulation of Cancer Progression: Anti-Tumor or Pro-Tumor Activity?

Shi, D. (2022) · Cancers · doi:10.3390/cancers14071843 · Cited by 19

Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma

Webster, N. J. G., Kumar, D., & Wu, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-52237-7 · Cited by 22

Genome Sequencing and RNA-Motif Analysis Reveal Novel Damaging Noncoding Mutations in Human Tumors

Singh, B., Trincado, J. L., Tatlow, P., Piccolo, S., & Eyras, E. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0601 · Cited by 20

Aberrant DNA methylation defines isoform usage in cancer, with functional implications

Chen, Y.-C., & Elnitski, L. L. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007095 · Cited by 19

Temporal Dynamic Analysis of Alternative Splicing During Embryonic Development in Zebrafish

Liu, Z., Wang, W., Li, X., Zhao, X., Zhao, H., Yang, W., Zuo, Y., Cai, L., & Xing, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.879795 · Cited by 18

Multilayered control of exon acquisition permits the emergence of novel forms of regulatory control

Avgan, N., Wang, J. I., Fernández-Chamorro, J., & Weatheritt, R. J. (2019) · Genome biology · doi:10.1186/s13059-019-1757-5 · Cited by 20

Role of Alternative Splicing in Prostate Cancer Aggressiveness and Drug Resistance in African Americans

Olender, J., & Lee, N. H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-22254-3_10 · Cited by 18

TfR1 Extensively Regulates the Expression of Genes Associated with Ion Transport and Immunity

Huang, N. J., Zhan, L., Cheng, Y., Wang, X., Wei, Y., Wang, Q., & Li, W. (2020) · Current Medical Science · doi:10.1007/s11596-020-2208-y · Cited by 17

OncoSplicing 3.0: an updated database for identifying RBPs regulating alternative splicing events in cancers

Zhang, Y., Liu, K., Xu, Z., Li, B., Wu, X., Fan, R., Yao, X., Wu, H., Duan, C., Gong, Y. Q., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1098 · Cited by 18

Comprehensive Analysis of APA Events and Their Association With Tumor Microenvironment in Lung Adenocarcinoma

Zhang, Y., Shen, L., Shi, Q., Zhao, G., & Wang, F. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.645360 · Cited by 17

Intron retention is a robust marker of intertumoral heterogeneity in pancreatic ductal adenocarcinoma

Tan, D. J., Mitra, M., Chiu, A. M., & Coller, H. A. (2020) · npj Genomic Medicine · doi:10.1038/s41525-020-00159-4 · Cited by 17

Exploring the Metabolic Heterogeneity of Cancers: A Benchmark Study of Context-Specific Models

Jalili, M., Scharm, M., Wolkenhauer, O., Damaghi, M., & Salehzadeh‐Yazdi, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060496 · Cited by 15

Integration of CLIP experiments of RNA-binding proteins: a novel approach to predict context-dependent splicing factors from transcriptomic data

Carazo, F., Gimeno, M., Ferrer-Bonsoms, J. A., & Rubio, Á. (2019) · BMC Genomics · doi:10.1186/s12864-019-5900-1 · Cited by 16

The X-linked splicing regulator MBNL3 has been co-opted to restrict placental growth in eutherians

Spruce, T., Plass, M., Gohr, A., Ray, D., de Lagrán, M. M., Rot, G., Nóvoa, A., Burguera, D., Permanyer, J., Miret-Cuesta, M., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001615 · Cited by 16

Alternative splicing in bladder cancer: potential strategies for cancer diagnosis, prognosis, and treatment

Montero‐Hidalgo, A. J., Pérez‐Gómez, J. M., Martínez‐Fuentes, A. J., Gómez‐Gómez, E., Gahete, M. D., Jiménez‐Vacas, J. M., & Luque, R. M. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1760 · Cited by 17

Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5

Che, Y., Bai, M., Lu, K., & Fu, L. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23477 · Cited by 16

A supervised machine learning-based methodology for analyzing dysregulation in splicing machinery: An application in cancer diagnosis

Reyes, Ó., Pérez, E., Luque, R. M., Castano, J. P., & Ventura, S. (2020) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2020.101950 · Cited by 16

Using the structural diversity of RNA: protein interfaces to selectively target RNA with small molecules in cells: methods and perspectives

Li, A., Bouhss, A., Clément, M., Bauvais, C., Taylor, J. P., Bollot, G., & Pastré, D. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1298441 · Cited by 15

Splicing diversity enhances the molecular classification of pituitary neuroendocrine tumors

Huang, Y., Guo, J., Han, X., Zhao, Y., Li, X., Xing, P., Liu, Y., Sun, Y., Wu, S., Lv, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56821-x · Cited by 17

Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells

Belloni, E., Matteo, A. D., Pradella, D., Vacca, M., Wyatt, C. D. R., Alfieri, R. R., Maffia, A., Sabbioneda, S., & Ghigna, C. (2019) · Cells · doi:10.3390/cells8121498 · Cited by 15

RBPTD: a database of cancer-related RNA-binding proteins in humans

Li, K., Guo, Z., Zhai, X.-M., Yang, X., Wu, Y.-S., & Liu, T. (2020) · Database · doi:10.1093/database/baz156 · Cited by 15

DNA- and RNA-Binding Proteins Linked Transcriptional Control and Alternative Splicing Together in a Two-Layer Regulatory Network System of Chronic Myeloid Leukemia

Wang, C., Zong, X., Wu, F., Leung, R. W. T., Hu, Y., & Qin, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.920492 · Cited by 14

USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28

Xu, H., Wang, T., Nie, H., Sun, Q., Jin, C., Yang, S., Chen, Z., Wang, X., Tang, J., Feng, Y., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03178-y · Cited by 16

Ginsenoside Rk1 inhibits HeLa cell proliferation through an endoplasmic reticulum signaling pathway

Li, Q., Sun, H., Liu, S., Tang, J., Liu, S., Yin, P., Mi, Q., Liu, J., Yu, L., & Bi, Y. (2023) · Journal of Ginseng Research · doi:10.1016/j.jgr.2023.04.004 · Cited by 13

A Novel TGF-β-Related Signature for Predicting Prognosis, Tumor Microenvironment, and Therapeutic Response in Colorectal Cancer

Tao, B., Yi, C., Ma, Y., Li, Y., Zhang, B., Geng, Y., Chen, Z., Ma, X., & Chen, J. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10591-7 · Cited by 13

Biological functions and prognostic value of RNA Binding Proteins in clear cell Renal Cell Carcinoma

Zhu, Z., He, A., Lin, L., Xu, C., Cai, T., & Lin, J. (2020) · Journal of Cancer · doi:10.7150/jca.49175 · Cited by 13

Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing

Yao, X., Zhou, H., Duan, C., Wu, X., Li, B., Liu, H., & Zhang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1096494 · Cited by 13

A functional network of gastric-cancer-associated splicing events controlled by dysregulated splicing factors

Cheng, S., Ray, D., Lee, R. T. H., Naripogu, K. B., Yusoff, P., Goh, P., Liu, Y., Suzuki, Y., Das, K., Chan, H. S., et al. (2020) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa013 · Cited by 13

The Prognostic Signature of Head and Neck Squamous Cell Carcinoma Constructed by Immune-Related RNA-Binding Proteins

Ming, R., Li, X., Wang, E., Wei, J., Liu, B., Zhou, P., Yu, W., Zong, S., & Xiao, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.795781 · Cited by 13

A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1

Closa, A., Reixachs‐Solé, M., Fuentes-Fayos, A. C., Hayer, K. E., Melero, J. L., Adriaanse, F. R. S., Bos, R. S., Torres-Diz, M., Hunger, S. P., Roberts, K. G., et al. (2022) · NAR Cancer · doi:10.1093/narcan/zcac041 · Cited by 12

Proteomic and Transcriptomic Analysis Identify Spliceosome as a Significant Component of the Molecular Machinery in the Pituitary Tumors Derived from POU1F1- and NR5A1-Cell Lineages

Taniguchi‐Ponciano, K., Peña-Martínez, E., Silva-Román, G., Vela-Patiño, S., Guzmán-Ortiz, A. L., Quezada, H., Apo, E. G., Chávez-Macías, L., Mercado-Medrez, S., Vargas‐Ortega, G., et al. (2020) · Genes · doi:10.3390/genes11121422 · Cited by 12

A Transcriptome-Wide Isoform Landscape of Melanocytic Nevi and Primary Melanomas Identifies Gene Isoforms Associated with Malignancy

Hakobyan, S., Loeffler‐Wirth, H., Arakelyan, A., Binder, H., & Kunz, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137165 · Cited by 12

Genome-Wide Gene Expression Profiles Reveal Distinct Molecular Characteristics of the Goose Granulosa Cells

Gao, G., Hu, S., Zhang, K., Wang, H., Xie, Y., Zhang, C., Wu, R., Zhao, X., Zhang, H., & Wang, Q. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.786287 · Cited by 12

Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer

Ni, X., Chen, C., Cui, G., Ding, W., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932876 · Cited by 12

The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells

Elhasnaoui, J., Ferrero, G., Miano, V., Cutrupi, S., & Bortoli, M. D. (2021) · Cancers · doi:10.3390/cancers13246261 · Cited by 9

AS-CMC: a pan-cancer database of alternative splicing for molecular classification of cancer

Park, J., Lee, J., Lee, M., & Chung, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-25584-6 · Cited by 12

Depletion of somatic mutations in splicing-associated sequences in cancer genomes

Hurst, L. D., & Batada, N. N. (2017) · Genome biology · doi:10.1186/s13059-017-1337-5 · Cited by 10

Differential alternative RNA splicing and transcription events between tumors from African American and White patients in The Cancer Genome Atlas

Abo, M. A., Hyslop, T., Qin, X., Owzar, K., George, D. J., Patierno, S. R., & Freedman, J. A. (2021) · Genomics · doi:10.1016/j.ygeno.2021.02.020 · Cited by 11

OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicinePreprint

López‐Cortés, A., Paz‐y‐Miño, C., Guerrero, S. X., Cabrera‐Andrade, A., Barigye, S. J., Munteanu, C. R., González‐Díaz, H., Pazos, A., Pérez‐Castillo, Y., & Tejera, E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/638866 · Cited by 12

Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration

Han, L., Wang, C.-P., & Han, S.-L. (2018) · médecine/sciences · doi:10.1051/medsci/201834f114 · Cited by 10

Dissection of molecular and histological subtypes of papillary thyroid cancer using alternative splicing profiles

Park, J., Kim, D., Lee, J., Park, H., Ryu, B. Y., Kim, J. H., Lee, S. H., & Chung, Y. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00740-0 · Cited by 14

A Regulatory Axis between Epithelial Splicing Regulatory Proteins and Estrogen Receptor α Modulates the Alternative Transcriptome of Luminal Breast Cancer

Elhasnaoui, J., Ferrero, G., Miano, V., Franchitti, L., Tarulli, I., Tarrero, L. C., Cutrupi, S., & Bortoli, M. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147835 · Cited by 10

SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells

Zhou, J., Chen, W., He, Q., Chen, D., Li, C., Jiang, C., Ding, Z., & Qian, Q. (2022) · PeerJ · doi:10.7717/peerj.14084 · Cited by 10

Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort

Liu, W., Li, C., Xu, W., Liu, X., Tang, H.-D., & Huang, H. (2020) · Aging · doi:10.18632/aging.103491 · Cited by 9

ZMAT2 condensates regulate the alternative splicing of TRIM28 to reduce cellular ROS accumulation, thereby promoting the proliferation of HCC cells

Zhu, Y.-N., Li, J., Li, S., Yang, Z., Qiao, Z., Gu, X., He, Z., Wu, D., Ma, X., Yao, S., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01790-9 · Cited by 9

Roles and mechanisms of aberrant alternative splicing in melanoma — implications for targeted therapy and immunotherapy resistance

Chen, W., Geng, D., Chen, J., Han, X., Xie, Q., Guo, G., Chen, X., Zhang, W., Tang, S., & Zhong, X. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03280-x · Cited by 11

Copy number alterations associated with clinical features in an underrepresented population with breast cancer

Peres, R. M. R., Carvalho, B. S., Anurag, M., Lei, J. T., Conz, L., Gonçalves, R., Cardoso-Filho, C., Ramalho, S., Silva, G. R. D. P., Derchain, S., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.750 · Cited by 10

Systematically Dissecting the Function of RNA-Binding Proteins During Glioma Progression

Wang, J., Qi, J., & Hou, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01394 · Cited by 9

Predicting RBP Binding Sites of RNA With High-Order Encoding Features and CNN-BLSTM Hybrid Model

Wang, Z., Dai, Q., Song, J., Duan, X., Yang, H., & Yang, Z. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3083930 · Cited by 9

Profiling the Binding Activities of Peptides and Inhibitors to the U2 Auxiliary Factor Homology Motif (UHM) Domains

Yuan, X., Howie, K. L., Sabzvar, M. K., Chinnaswamy, K., Stuckey, J. A., & Yang, C. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00537 · Cited by 9

Events of alternative splicing in head and neck cancer via RNA sequencing – an update

Sharma, V., Nandan, A., Singh, H., Agarwal, S., Tripathi, R., Sinha, D. N., & Mehrotra, R. (2019) · BMC Genomics · doi:10.1186/s12864-019-5794-y · Cited by 9

Identification of fatty acid metabolism-related clusters and immune infiltration features in hepatocellular carcinoma

Ren, Z., Gao, D., Luo, Y., Song, Z., Wu, G., Qi, N., Li, A., & Liu, X. (2023) · Aging · doi:10.18632/aging.204557 · Cited by 8

Broad regulation of gene isoform expression by Wnt signaling in cancer

Idris, M., Harmston, N., Petretto, E. G., Madan, B., & Virshup, D. M. (2019) · RNA · doi:10.1261/rna.071506.119 · Cited by 8

Alternative RNA splicing in stem cells and cancer stem cells: Importance of transcript-based expression analysis

Ebrahimie, E., Rahimirad, S., Tahsili, M. R., & Dehcheshmeh, M. M. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i10.1394 · Cited by 8

Alternative Splicing of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Is Regulated by RBFOX2 in Lymphoid Malignancies

Cooper, A. M., Nutter, C. A., Kuyumcu‐Martinez, M. N., & Wright, C. W. (2022) · Molecular and Cellular Biology · doi:10.1128/mcb.00503-21 · Cited by 8

Aberrant RNA Splicing Events Driven by Mutations of RNA-Binding Proteins as Indicators for Skin Cutaneous Melanoma Prognosis

Mei, C., Song, P.-Y., Zhang, W., Zhou, H., Li, X., & Liu, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.568469 · Cited by 8

YTHDC1 promotes the malignant progression of gastric cancer by promoting ROD1 translocation to the nucleus

Dong, D., Wei, J., Wang, W., Zhou, H., Hong, L., Ji, G., & Yang, X. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09859-4 · Cited by 7

Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Raupach, E. A., Hegde, A. M., Garcia‐Mansfield, K., Alcantara, M. B., Rose, D. L., Halperin, R. F., Orlando, K. A., Lang, J. D., Sharma, R., David‐Dirgo, V., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-0044 · Cited by 7

Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4

Naqvi, A. S., Sullivan, P. J., Corbett, R. J., Sehgal, P. D., Conkrite, K. L., Rathi, K. S., Ennis, B., Hayer, K. E., Zhang, B., Brown, M., et al. (2026) · Neuro-Oncology Pediatrics · doi:10.1093/neuped/wuag009 · Cited by 7

Comprehensive characterization of the alternative splicing landscape in ovarian cancer reveals novel events associated with tumor-immune microenvironment

Sun, D., Zhao, X., Yu, Y., Li, W., Gu, P., Zhi, Z., & Xu, D. (2022) · Bioscience Reports · doi:10.1042/bsr20212090 · Cited by 7

Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis

He, Q., Fan, B., Du, P., & Jin, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.806989 · Cited by 7

Alternative splicing regulation and its therapeutic potential in bladder cancer

Li, L., Jin, T., Hu, L., & Ding, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1402350 · Cited by 6

Alternative splicing: a new breakthrough for understanding tumorigenesis and potential clinical applications

Park, J., Park, J., & Chung, Y. (2023) · Genes & Genomics · doi:10.1007/s13258-023-01365-x · Cited by 6

Construction of cuproptosis‑associated prognostic signature in colon adenocarcinoma based on bioinformatics and RT‑qPCR analysis

Yang, G., Wang, H., & Sun, B. (2023) · Oncology Letters · doi:10.3892/ol.2023.13677 · Cited by 8

Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma

Rong, M., Zhu, Z.-H., Guan, Y., Li, M., Zheng, J., Huang, Y.-Q., Wei, D., Li, Y.-M., Wu, X., Bu, H.-P., et al. (2020) · PeerJ · doi:10.7717/peerj.8380 · Cited by 6

A Systematic Identification of RNA-Binding Proteins (RBPs) Driving Aberrant Splicing in Cancer

Lobato‐Fernández, C., Gimeno, M., Martín, A. S., Anorbe, A., Rubio, A., & Ferrer-Bonsoms, J. A. (2024) · Biomedicines · doi:10.3390/biomedicines12112592 · Cited by 5

The Expression Pattern of Ferroptosis-Related Genes in Colon Adenocarcinoma: Highly Correlated to Tumor Microenvironment Characteristics

Liu, J., Li, H., Zhao, S., Lin, R., Yu, J., & Fan, N. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.837941 · Cited by 5

Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer

Zhang, Z., Chen, P., & Yun, J. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1156095 · Cited by 5

Aberrant splicing in human cancer: An RNA structural code point of view

Apostolidi, M., & Stamatopoulou, V. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1137154 · Cited by 5

The RNA ‐Binding Proteins MCPIP2 and IGF2BP1 Competitively Modulate Breast Tumor Angiogenesis by Antagonizing VEGFA mRNA Stability and Expression

Lu, W., Li, H., Liu, X., Li, A., & Xiu, R. (2025) · The FASEB Journal · doi:10.1096/fj.202500461r · Cited by 4

Environmentally relevant concentrations of 2,3,7,8-TCDD induced inhibition of multicellular alternative splicing and transcriptional dysregulation

Zhao, B., Deng, J., Ma, M., Li, N., Zhou, J., Li, X., & Luan, T. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170892 · Cited by 4

ASpediaFI: Functional Interaction Analysis of Alternative Splicing Events

Lee, K., Yu, D., Hyung, D., Cho, S. Y., & Park, C. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.10.004 · Cited by 4

Thioredoxin1 Binding Metastasis-Associated Lung Adenocarcinoma Transcript 1 Attenuates Inflammation and Apoptosis after Intracerebral Hemorrhage

Chen, R., Xie, Q., Xie, L., Huang, J., Hu, L., Lü, H., Shi, P., He, Q., Zhang, Q., Gong, C., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0507 · Cited by 4

A Supervised Methodology for Analyzing Dysregulation in Splicing Machinery: An Application in Cancer Diagnosis

Reyes, Ó., Luque, R. M., Castano, J. P., & Ventura, S. (2019) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2019.00035 · Cited by 4

Development and validation of an individual alternative splicing prognostic signature in gastric cancer

Lou, S., Zhang, J., Zhai, Z., Yin, X., Wang, Y., Fang, T., & Xue, Y. (2021) · Aging · doi:10.18632/aging.202507 · Cited by 4

The Many Roads from Alternative Splicing to Cancer: Molecular Mechanisms Involving Driver Genes

Gimeno-Valiente, F., López‐Rodas, G., Castillo, J., & Franco, L. (2024) · Cancers · doi:10.3390/cancers16112123 · Cited by 3

Deciphering splicing heterogeneity at single-cell resolution by SCSES

Xiao, W., Lv, X., Guo, D. H., Han, N., Zhou, L., Wang, P., & Liu, Z. (2025) · Nature Communications · doi:10.1038/s41467-025-64517-5 · Cited by 6

MRAS: Master Regulator Analysis of Alternative Splicing

Zhou, L., Huang, Y., Zhao, Y., Guo, D. H., Xiao, W., Xu, R., Lv, X., Wu, S., Jing, S., & Liu, Z. (2025) · Advanced Science · doi:10.1002/advs.202414493 · Cited by 3

Identification of heterogeneous nuclear ribonucleoprotein as a candidate biomarker for diagnosis and prognosis of hepatocellular carcinoma

Du, Y., Ma, X.-O., Wang, D., Wang, Y., Zhang, T., Bai, L., Liu, Y., & Chen, S. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-468 · Cited by 3

A novel Cuprotosis-related signature predicts the prognosis and selects personal treatments for melanoma based on bioinformatics analysis

Hu, B., Hounye, A. H., Wang, Z., Qi, M., & Zhang, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1108128 · Cited by 3

Splicing signature database development to delineate cancer pathways using literature mining and transcriptome machine learning

Lee, K., Hyung, D., Cho, S. Y., Yu, N., Hong, S., Kim, J., Kim, S., Han, J., & Park, C. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.02.052 · Cited by 3

DASES: a database of alternative splicing for esophageal squamous cell carcinoma

Chen, Y., Kuang, Y., Luan, S., Yang, Y., Ying, Z., Li, C., Gao, J., Yuan, Y., & Yu, H. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1237167 · Cited by 3

Characterization of Alternative Splicing in High-Risk Wilms’ Tumors

Trink, Y., Urbach, A., Dekel, B., Hohenstein, P., Goldberger, J., & Tomer Kalisky, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084520 · Cited by 3

Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features

Sanjuan‐Sanjuan, A., Alors‐Pérez, E., Sánchez‐Frías, M., Monserrat-Barbudo, J. A., Falguera‐Uceda, M. I., Heredero, S., & Luque, R. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136929 · Cited by 3

PAIP1 binds to pre-mRNA and regulates alternative splicing of cancer pathway genes including VEGFA

Zheng, J., Zhang, X., Xue, Y., Shao, W., Wei, Y., Mi, S., Yang, X., Hu, L., Zhang, Y., & Ming, L. (2024) · BMC Genomics · doi:10.1186/s12864-024-10530-9 · Cited by 4

dSreg: a Bayesian model to integrate changes in splicing and RNA-binding protein activity

Martí‐Gómez, C., Lara‐Pezzi, E., & Sánchez‐Cabo, F. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz915 · Cited by 3

La protein contributes to cells proliferation and migration and serves as a potential therapeutic target for hepatocellular carcinoma

Pan, J., Tong, S., Kong, L., Zhu, J., & Tang, J. Y. (2020) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13370 · Cited by 3

TranscriptAchilles: a genome-wide platform to predict isoform biomarkers of gene essentiality in cancer

Carazo, F., Campuzano, L., Cendoya, X., Planes, F. J., & Rubio, Á. (2019) · GigaScience · doi:10.1093/gigascience/giz021 · Cited by 3

A novel immune-related RNA-binding proteins signature to predict survival and therapeutic responses in prostate cancer

Wang, Z., Zhang, Y., Jiang, C., & Gong, B. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02782-2 · Cited by 2

Proto-oncogene DEK binds to pre-mRNAs and regulates the alternative splicing of Hippo signaling genes in HeLa cells

Liu, D., Sun, W., Han, J., Wang, C., Chen, D., Wu, Y., Chang, Y., & Yang, B. (2025) · Molecular Genetics and Genomics · doi:10.1007/s00438-025-02226-w · Cited by 2

Identification of recurrent regulated alternative splicing events across human solid tumors

Danan-Gotthold, M., Golan‐Gerstl, R., Eisenberg, E., Meir, K., Karni, R., & Levanon, E. Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv210 · Cited by 154

OncoSplicing 3.0: an updated database for identifying RBPs regulating alternative splicing events in cancers

Zhang, Y., Liu, K., Xu, Z., Li, B., Wu, X., Fan, R., Yao, X., Wu, H., Duan, C., Gong, Y. Q., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1098 · Cited by 18

Landscape of Somatic Mutations in RNA Splicing Regulatory Elements in Cancer

Singh, B., & Eyras, E. (2016) · Figshare · doi:10.6084/m9.figshare.4485491

Alternative splicing perturbation landscape identifies RNA binding proteins as potential therapeutic targets in cancer

Li, J., Pan, T., Chen, L., Wang, Q., Chang, Z., Zhou, W., Li, X., Xu, G., Li, Y., Li, Y., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.04.005 · Cited by 26

Alternative splicing and breast cancer

Dutertre, M., Vagner, S., & Auboeuf, D. (2010) · RNA Biology · doi:10.4161/rna.7.4.12152 · Cited by 44